Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 673.50
Bid: 674.50
Ask: 675.00
Change: -2.00 (-0.30%)
Spread: 0.50 (0.074%)
Open: 676.00
High: 676.00
Low: 669.50
Prev. Close: 675.50
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

20 Apr 2012 07:00

20 April 2012 - Tate & Lyle PLC

SALE OF CITRIC ACID JOINT VENTURE

Tate & Lyle announces that it has reached agreement to sell its 50% share in Sucromiles, its Colombian citric acid joint venture, to its long-standing partner in this business, Organización Ardila Lülle, for total cash consideration of US $31.5 million (£19.6*m). Following completion of the sale, which is conditional upon Colombian competition authority approval, Tate & Lyle will continue to distribute citric acid products from Sucromiles outside the Colombian market.

END

For more information contact Tate & Lyle PLC:

Mathew Wootton, Group VP, Investor and Media Relations
Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7500 100 320
Andrew Lorenz (FTI Consulting), Media Relations
Tel: +44 (0) 20 7269 7113 or Mobile: +44 (0) 7775 641 807

About Tate & Lyle:

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, operating from over 30 production facilities around the world.

Tate & Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.

Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2011, Tate & Lyle sales totalled £2.7 billion. http://www.tateandlyle.com.

SPLENDA® is a trademark of McNeil Nutritionals, LLC.

About Organización Ardila Lülle:

Organización Ardila Lülle is a leading Colombian Industrial Group in the Beverage, Agro industrial, Radio, Television, and Packaging sectors among others.

*£/US$ exchange rate 1.61

Copyright Business Wire 2012

Date   Source Headline
2nd Feb 20159:23 amBUSTotal Voting Rights
12th Jan 20153:32 pmBUSDirector/PDMR Shareholding
7th Jan 20152:32 pmBUSDirector/PDMR Shareholding
6th Jan 20159:04 amBUSDirector/PDMR Shareholding
2nd Jan 201511:24 amBUSBlocklisting Interim Review
2nd Jan 201511:00 amBUSTotal Voting Rights
19th Dec 20145:22 pmBUSTransaction in Own Shares
18th Dec 20145:13 pmBUSTransaction in Own Shares
17th Dec 20145:39 pmBUSTransaction in Own Shares
5th Dec 20145:26 pmBUSTransaction in Own Shares
5th Dec 20145:25 pmBUSHolding(s) in Company
5th Dec 201410:14 amBUSDirector/PDMR Shareholding
5th Dec 201410:05 amBUSDirector/PDMR Shareholding
4th Dec 20145:16 pmBUSTransaction in Own Shares
3rd Dec 20145:41 pmBUSTransaction in Own Shares
2nd Dec 20145:19 pmBUSTransaction in Own Shares
1st Dec 20145:51 pmBUSTransaction in Own Shares
1st Dec 201411:10 amBUSTotal Voting Rights
18th Nov 20142:34 pmBUSDirector/PDMR Shareholding
11th Nov 201410:42 amBUSDirector/PDMR Shareholding
6th Nov 20145:07 pmBUSDirector/PDMR Shareholding
6th Nov 20147:00 amBUSHalf-yearly Report
29th Oct 201410:00 amBUSBoard changes
16th Oct 20145:55 pmBUSHolding(s) in Company
1st Oct 20145:19 pmBUSHolding(s) in Company
1st Oct 20141:29 pmBUSTotal Voting Rights
29th Sep 20145:39 pmBUSDirector/PDMR Shareholding
26th Sep 20141:47 pmBUSDirector/PDMR Shareholding
23rd Sep 20147:00 amBUSTrading Statement
22nd Sep 20146:24 pmBUSHolding(s) in Company
19th Sep 201412:48 pmBUSHolding(s) in Company
1st Sep 20149:37 amBUSTotal Voting Rights
4th Aug 20144:53 pmBUSDirector/PDMR Shareholding
1st Aug 20144:38 pmBUSHolding(s) in Company
1st Aug 201412:05 pmBUSHolding(s) in Company
1st Aug 201410:00 amBUSTotal Voting Rights
31st Jul 20145:26 pmBUSDirector/PDMR Shareholding
31st Jul 201410:42 amBUSDirector/PDMR Shareholding
24th Jul 20143:38 pmBUSResult of AGM
24th Jul 20147:00 amBUSInterim Management Statement
8th Jul 201410:01 amBUSDirector/PDMR Shareholding
2nd Jul 20146:02 pmBUSDirector/PDMR Shareholding
1st Jul 20149:54 amBUSBlocklisting Interim Review
1st Jul 20149:45 amBUSTotal Voting Rights
25th Jun 20142:55 pmBUSDirector Declaration
24th Jun 20146:05 pmBUSDirector/PDMR Shareholding
24th Jun 20147:00 amBUSDirectorate Change
23rd Jun 20144:47 pmBUSAnnual Financial Report
20th Jun 201410:14 amBUSDirector/PDMR Shareholding
6th Jun 20144:59 pmBUSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.